QTEX$1.12+0.01%
QTREX Quantum Ltd.
Sector: Surgical & Medical Instruments & ApparatusIndustry: Computer HardwareCountry: ILExchange: Nasdaq
Mkt Cap:$75.13M
Float & O/S:
Inst Own:
DilutionScan read 40 of QTREX Quantum Ltd.'s SEC filings and found 9 warrant series, 3 ATM programs, 1 equity line, 4 shelf registrations, 3 S-1 registrations and 4 completed offerings on file for QTEX. Analysis updated Oct 4, 2026.
Signal8 Summary
QTEX
Early-stage pivot, burning cash fast
Snapshot
QTREX is a tiny, newly-pivoted quantum-hardware company (formerly a medical device maker) just 86 days into its new AME/Quantum segment. H1 2026 revenue was $1.55M, up 438%, at a solid 61% gross margin, but the company lost $6.4M and burned $3.9M in operating cash.
What's Happening Right Now
- : QTREX's cryogenic interconnect was independently tested at 20 mK by an unnamed 'leading quantum computing company,' with a binding agreement said to be in the works.
- : H1 2026 revenue hit $1.55M (up 438%) at 61% gross margin, but QTREX posted a $6.4M net loss and burned $3.9M in operating cash, following a $10M share offering.
- : One of Israel's three largest defense companies began deploying QTREX's AME technology under a confidential joint program with a potential multi-tens-of-millions revenue pathway, though later phases still need definitive agreements.
- : QTREX priced a $10 million registered direct offering of 11.1 million shares at-the-market to fund working capital.
- : Registered 6.79M shares for sale on Form S-1.
- : QTREX secured a commercial purchase order from an unnamed international government-owned company and began production, though order size wasn't disclosed.
- : Registered 6.67M shares for sale on Form F-3.
- : Raised $10.00M in gross proceeds through a private placement (PIPE), with warrants over 2.77M shares.
